CRL Stock Ownership Activity

CHARLES RIVER LABORATORIES 13F holders

4 value investing gurus have made changes to the CHARLES RIVER LABORATORIES (CRL) position according to the gurus' latest SEC quarterly report(s). CRL has been completely sold out by 1 guru(s), the number of CRL shares has been increased by 1, decreased by 2 super investor(s).

Which gurus or hedge funds are buying CRL now?

According to the latest SEC filing(s) CHARLES RIVER LABORATORIES (CRL) has been bought by John W. Rogers Jr. - Ariel Appreciation Fund (added shares +3.21%).

To see more about who is investing in CHARLES RIVER LABORATORIES (CRL), please go to the CRL ownership page.

2020 Q1 (1 result)
John W. Rogers Jr.
-37.91%
-61,600
-0.91%
1.50%
Current price: $155.55 23.25% Reported price*: $126.21
2019 Q4 (1 result)
John W. Rogers Jr.
-3.10%
-5,200
-0.06%
1.89%
Current price: $155.55 1.83% Reported price*: $152.76
2019 Q3 (1 result)
John W. Rogers Jr.
buy
+167,680
+1.72%
1.72%
Current price: $155.55 17.51% Reported price*: $132.37
2018 Q1 (1 result)
Robert Olstein
-100.00%
-48,235
-0.67%
0.00%
Current price: $155.55 42.13% Reported price*: $109.44
2017 Q4 (1 result)
Robert Olstein
-19.76%
-11,877
-0.17%
0.00%
Current price: $155.55 42.13% Reported price*: $109.44
2017 Q3 (1 result)
Robert Olstein
-22.07%
-17,023
-0.24%
0.84%
Current price: $155.55 44.01% Reported price*: $108.02
2017 Q2 (1 result)
Robert Olstein
-28.62%
-30,920
-0.40%
0.99%
Current price: $155.55 53.79% Reported price*: $101.15
2017 Q1 (1 result)
Robert Olstein
-20.57%
-27,980
-0.32%
1.24%
Current price: $155.55 72.92% Reported price*: $89.95
2016 Q4 (1 result)
Robert Olstein
+58.87%
+50,410
+0.50%
1.34%
Current price: $155.55 104.15% Reported price*: $76.19
2016 Q3 (1 result)
Robert Olstein
+53.17%
+29,724
+0.33%
0.94%
Current price: $155.55 86.64% Reported price*: $83.34
2016 Q2 (1 result)
Robert Olstein
+130.18%
+31,615
+0.35%
0.62%
Current price: $155.55 88.70% Reported price*: $82.43
2016 Q1 (1 result)
Robert Olstein
buy
+24,286
+0.25%
0.25%
Current price: $155.55 104.86% Reported price*: $75.93
2015 Q1 (1 result)
Robert Olstein
-100.00%
-32,000
-0.22%
0.00%
Current price: $155.55 144.48% Reported price*: $63.63
2014 Q4 (1 result)
Robert Olstein
-73.55%
-89,000
-0.69%
0.00%
Current price: $155.55 144.48% Reported price*: $63.63
2014 Q3 (1 result)
Robert Olstein
-9.02%
-12,000
-0.09%
0.94%
Current price: $155.55 160.36% Reported price*: $59.74
2014 Q2 (1 result)
Robert Olstein
+64.20%
+52,000
+0.38%
0.96%
Current price: $155.55 190.65% Reported price*: $53.52
2014 Q1 (1 result)
Robert Olstein
-52.07%
-88,000
-0.73%
0.67%
Current price: $155.55 157.76% Reported price*: $60.35
2013 Q4 (1 result)
Robert Olstein
-3.98%
-7,000
-0.05%
1.28%
Current price: $155.55 193.26% Reported price*: $53.04
2013 Q2 (1 result)
Robert Olstein
buy
+176,000
+1.16%
1.16%
Current price: $155.55 279.13% Reported price*: $41.03
19 of 69

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.